What Were The Results Of Repeat Treatment With The Capsaicin 8% Dermal Patch Over 52 Weeks? Sustained Pain Relief & Safety Confirmed

In a 52-week study, repeat treatment with the capsaicin 8% dermal patch successfully provided sustained pain relief for patients with peripheral neuropathic pain. The study concluded that this long-term use did not produce negative neurological effects when compared to standard care alone and was generally well tolerated.

The core takeaway is that the capsaicin 8% patch represents a viable and safe long-term treatment strategy, offering sustained, localized pain relief without evidence of long-term nerve damage.

What were the results of repeat treatment with the capsaicin 8% dermal patch over 52 weeks? Sustained Pain Relief & Safety Confirmed

How the Capsaicin 8% Patch Works

A Targeted Mechanism

The capsaicin 8% dermal patch is an adhesive that delivers a high concentration of synthetic capsaicin directly to the skin over the area of pain.

Targeting the TRPV-1 Receptor

Capsaicin is a highly selective agonist for the transient receptor potential vanilloid-1 (TRPV-1). This receptor is found on pain-sensing nerve fibers and, when overstimulated by high-concentration capsaicin, becomes desensitized, effectively quieting the pain signals.

Key Findings from the 52-Week Study

Sustained Pain Relief

The primary finding over the 52-week period was that repeated applications provided sustained pain relief. This demonstrates its efficacy as a long-term management tool, not just a short-term solution.

Favorable Neurological Safety

Crucially, the study found no negative neurological effects compared to the group receiving standard of care alone. This addresses a key concern about the long-term safety of using a high-concentration neuroactive compound.

Understanding the Trade-offs: Side Effects and Tolerability

Generally Well Tolerated

Overall, the capsaicin 8% patch was considered generally well tolerated by patients throughout the year-long study.

Common Adverse Events

The most common side effects were transient application-site reactions. These are temporary and localized to the area where the patch was applied, such as redness, stinging, or a burning sensation.

Making the Right Choice for Your Treatment Plan

The results position the capsaicin 8% dermal patch as a useful addition to the available options for managing peripheral neuropathic pain.

If your primary focus is long-term pain management: The 52-week study confirms that repeat treatments can provide sustained and consistent relief.
If your primary focus is avoiding systemic side effects: As a topical treatment, the patch acts locally, minimizing the body-wide effects often associated with oral pain medications.
If your primary focus is nerve health: The study's finding of no negative neurological effects provides reassurance about its long-term safety profile.

This treatment offers a targeted approach to managing chronic neuropathic pain effectively and safely over an extended period.

Summary Table:

Key Finding	Details
Sustained Pain Relief	Repeat applications provided consistent, long-term pain management over 52 weeks.
Neurological Safety	No negative neurological effects were observed compared to standard care alone.
Tolerability	Generally well tolerated, with transient, localized application-site reactions being the most common side effect.

Looking for a reliable manufacturing partner for advanced dermal patches like the capsaicin 8% patch?

At Enokon, we are a bulk manufacturer of high-quality, reliable transdermal patches and pain plasters. We partner with healthcare and pharmaceutical distributors and brands to bring their innovative treatment ideas to life.

Benefit from our technical expertise for custom R&D and development, ensuring your product meets the highest standards of efficacy and safety. Let us help you deliver targeted pain relief to patients.

Contact our experts today to discuss your project needs.